Tengjun Biotechnology Corp.
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $11,346,841 and profit margin reached 8%. Total operating expenses were $124,350,261.

Profit Margin

Tengjun Biotechnology Corp. (OTC:TJBH): Profit margin
2013 0 -21.31K
2014 0 -108.36K
2015 0 -74.70K
2016 0 -60.66K
2017 0 -48.23K
2018 0 -47.80K
2019 0 -80.23K
2020 290 -75.46K -26021.38%
2021 0 -748.17K
2022 150.13M 11.34M 7.56%

TJBH Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
150.13M02900000000
Cost of revenue
9.72M318.44K273.16K0000000
Gross profit
140.41M-318.44K-272.87K0000000
Operating exp.
Research and development
0000000000
Selling and marketing
123.15M28.49K68.80K0000000
Total operating expenses
124.35M738.23K32.27K39.49K29.89K32.48K36.82K64.89K103.09K20.45K
Operating income
16.06M-738.23K-32.27K-39.49K-29.89K-32.48K-36.82K-64.89K-103.09K-20.45K
Other income (expenses), net
-782.53K-9.29K-24.44K-20.37K-17.90K-15.74K-10K-9.81K-5.27K-864
Income before tax
15.28M-747.52K-53.86K-59.86K-47.80K-48.23K-60.66K-74.70K-108.36K-21.31K
Income tax expense
3.30M64921.59K20.37K0010K0-1K0
Net income
11.34M-748.17K-75.46K-80.23K-47.80K-48.23K-60.66K-74.70K-108.36K-21.31K
Earnings per share
Basic EPS
0.14-0.03-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Diluted EPS
0.14-0.03-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source